This work is licensed under the Creative Commons Attribution 4.0 International License.
Feldman, E.C., Nelson, R.W. (2004). Canine hyperadrenocorticism Cushings syndrome. In: Canine and Feline Endocrinology and Reproduction (p. 252). Elsevier Health Sciences.Search in Google Scholar
Kritsepi-Konstantinou, M., Oikonomidis, I.L. (2016). The interpretation of leukogram in dog and cat. HJCAM 5(2): 63.Search in Google Scholar
Ryad, N.M., Ramadan, E.S., Salem, N.Y., Saleh, I.A. (2021). Influence of dexamethasone administration on hematology, biochemistry, and thyroid hormones in dogs. Adv Anim Vet Sci. 9(1): 111-116. https://doi.org/10.17582/journal.aavs/2021/9.1.111.116Search in Google Scholar
Peterson, M.E. (2007). Diagnosis of hyperadrenocorticism in dogs. Clin Tech Small Anim Pract. 22(1): 2-11. https://doi.org/10.1053/j.ctsap.2007.02.007 PMid:17542191Search in Google Scholar
Behrend, E.N., Kooistra, H.S., Nelson, R., Reusch, C.E., Scott‐Moncrieff, J.C. (2013). Diagnosis of spontaneous canine hyperadrenocorticism: 2012 ACVIM consensus statement (small animal). J Vet Intern Med. 27(6): 1292-1304. https://doi.org/10.1111/jvim.12192 PMid:24112317Search in Google Scholar
Potts, G.O., Creange, J.E., Harding, H.R., Schane, H.P. (1978). Trilostane, an orally active inhibitor of steroid biosynthesis. Steroids 32(2): 257-267. https://doi.org/10.1016/0039-128X(78)90010-7 PMid:715820Search in Google Scholar
Eastwood, J.M., Elwood, C.M., Hurley, K.J. (2003). Trilostane treatment of a dog with functional adrenocortical neoplasia. J Small Anim Pract. 44(3): 126-131. https://doi.org/10.1111/j.1748-5827.2003.tb00133.x PMid:12653328Search in Google Scholar
Neiger, R., Hurley, K.J., Ramsey, I., O’Connor, J., Mooney, C.T. (2002). Trilostane treatment of 78 dogs with pituitary‐dependent hyperadrenocorticism. Vet Rec. 150(26): 799-804. https://doi.org/10.1136/vr.150.26.799 PMid:12120922Search in Google Scholar
Lemetayer, J., Blois, S. (2018). Update on the use of trilostane in dogs. Can Vet J. 59(4): 397-407.Search in Google Scholar
Bell, R., Neiger, R., McGrotty, Y., Ramsey, I.K. (2006). Study of the effects of once daily doses of trilostane on cortisol concentrations and responsiveness to adrenocorticotrophic hormone in hyperadrenocorticoid dogs. Vet Rec. 159(9): 277-281. https://doi.org/10.1136/vr.159.9.277 PMid:16946310Search in Google Scholar
Vaughan, M.A., Feldman, E.C., Hoar, B.R., Nelson, R.W. (2008). Evaluation of twice-daily, low-dose trilostane treatment administered orally in dogs with naturally occurring hyperadrenocor ticism. J Am Vet Med Assoc. 232(9): 1321-1328. https://doi.org/10.2460/javma.232.9.1321 PMid:18447776Search in Google Scholar
Feldman, E.C. (2011). Evaluation of twice-daily lower-dose trilostane treatment administered orally in dogs with naturally occurring hyperadrenocorticism. J Am Vet Med Assoc. 238(11): 1441-1451. https://doi.org/10.2460/javma.238.11.1441 PMid:21627507Search in Google Scholar
Teshima, T., Hara, Y., Takekoshi, S., Nezu, Y., Harada, Y., Yogo, T., Teramoto, A., Osaamura, R.Y., Tagawa, M. (2009). Trilostane-induced inhibition of cortisol secretion results in reduced negative feedback at the hypothalamic-pituitary axis. Domest Anim Endocrinol. 36(1): 32-44. https://doi.org/10.1016/j.domaniend.2008.10.002 PMid:19041802Search in Google Scholar
Gilor, C., Graves, T.K. (2011). Interpretation of laboratory tests for canine Cushing’s syndrome. Top Companion Anim Med. 26(2): 98-108. https://doi.org/10.1053/j.tcam.2011.03.001 PMid:21596349Search in Google Scholar
Fathman, L. (2005). Textbook of veterinary internal medicine. Elsevier SaundersSearch in Google Scholar
Jacoby, R.C., Owings, J.T., Ortega, T., Gosselin, R., Feldman, E.C. (2001). Biochemical basis for the hypercoagulable state seen in Cushing syndrome; discussion 1006-7. Arch Surg. 136(9): 1003-1006. https://doi.org/10.1001/archsurg.136.9.1003 PMid:11529821Search in Google Scholar
Galac, S. (2010). Recent developments in canine Cushings syndrome. Utrecht UniversitySearch in Google Scholar
Cho, K.D., Kang, J.H., Chang, D., Na, K.J., Yang, M.P. (2013). Efficacy of low‐ and high‐dose trilostane treatment in dogs (<5 kg) with pituitary‐dependent hyperadrenocorticism. J Vet Intern Med. 27(1): 91-98. https://doi.org/10.1111/jvim.12007 PMid:23167780Search in Google Scholar
Ettinger, S.J., Feldman, E.C. (2010). Textbook of veterinary internal medicine. 7th edition, 2086-2088.Search in Google Scholar
Alenza, D.P., Arenas, C., Lopez, M.L., Melian, C. (2006). Long-term efficacy of trilostane administered twice daily in dogs with pituitary-dependent hyperadrenocorticism. J Am Anim Hosp Assoc. 42(4): 269-276. https://doi.org/10.5326/0420269 PMid:16822765Search in Google Scholar